arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

CENTENE CORP

CNC
$74.16 ▼ -1.84 (-2.43%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
73 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

CENTENE CORP faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $36.6B
Dividend Yield —
Revenue Growth 1.9% ↘
Op. Margin -0.6% ↘
ROIC -0.4% ↘
FCF / Share $-7.82 ↘
Trailing P/E —
Price / Book 1.7x
FCF Yield —
Debt / Equity 0.70
info Valuation on last close. End-of-day price, Nov 5, 2026.

73-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$50.65B
↑ +1.9% —
Net Income Profit after all expenses
$-71.00M
↑ +98.9% —
Operating Margin Operating profit as % of sales
-0.6%
↓ -127.1% 21th
FCF / Share Free cash flow per share
$-7.82
↓ -213.0% —
Long-Term Debt Long-term obligations
$15.45B
↓ -3.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
26
Returns
22
Financial Health ↑
31
Cash Quality
12

bar_chart Data from SEC EDGAR XBRL filings

Synced 6 days ago 19 years · 73 quarters